Related Experiment Videos
The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase
1Lymphocyte Biology Section, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Abstract:
The proto-oncogene product Cbl has emerged as a negative regulator of a number of protein-tyrosine kinases, including the ZAP-70/Syk tyrosine kinases that are critical for signaling in hematopoietic cells. The evolutionarily conserved N-terminal tyrosine kinase-binding domain is required for Cbl to associate with ZAP-70/Syk and for their subsequent negative regulation. However, the role of the remaining C-terminal regions of Cbl remains unclear. Here, we used a COS-7 cell reconstitution system to address this question. Analysis of a series of C-terminally truncated Cbl mutants revealed that the N-terminal half of the protein, including the TKB and RING finger domains, was sufficient to mediate negative regulation of Syk. Further truncations, which delete the RING finger domain, abrogated the negative regulatory effects of Cbl on Syk. Point mutations of conserved cysteine residues or a histidine in the RING finger domain, which are required for zinc binding, abrogated the ability of Cbl to negatively regulate Syk in COS-7 cells and Ramos B lymphocytic cells. In addition, Syk-dependent transactivation of a serum response element-luciferase reporter in transfected 293T cells was reduced by wild type Cbl; mutations of the RING finger domain or its deletion abrogated this effect. These results establish the RING finger domain as an essential element in Cbl-mediated negative regulation of a tyrosine kinase and reveal that the evolutionarily conserved N-terminal half of the protein is sufficient for this function.
Insights
The Cbl proto-oncogene negatively regulates tyrosine kinases like Syk. Its N-terminal half, including the RING finger domain, is crucial for this function, as demonstrated in hematopoietic and B lymphocytic cells.
Area of Science:
- Cellular signaling
- Molecular biology
- Oncogene research
Background:
- Cbl is a proto-oncogene acting as a negative regulator of protein-tyrosine kinases.
- ZAP-70/Syk tyrosine kinases are vital for hematopoietic cell signaling.
- The N-terminal tyrosine kinase-binding domain (TKB) of Cbl is known to be essential for kinase association and regulation.
Purpose of the Study:
- To elucidate the role of Cbl's C-terminal regions in negative regulation of tyrosine kinases.
- To identify the specific domains within Cbl responsible for inhibiting Syk activity.
Main Methods:
- Utilized a COS-7 cell reconstitution system to study Cbl function.
- Generated and analyzed C-terminally truncated Cbl mutants.
- Introduced point mutations in the Cbl RING finger domain.
- Assessed Syk activity and downstream signaling using reporter assays in transfected cells.
Main Results:
- The N-terminal half of Cbl, encompassing the TKB and RING finger domains, was sufficient for negative regulation of Syk.
- Deletion or mutation of the RING finger domain abolished Cbl's ability to negatively regulate Syk.
- Wild-type Cbl reduced Syk-dependent transactivation, an effect abrogated by RING finger domain alterations.
Conclusions:
- The RING finger domain is essential for Cbl-mediated negative regulation of tyrosine kinases.
- The N-terminal half of Cbl is sufficient for its kinase inhibitory function.
- These findings clarify the functional domains of Cbl in regulating hematopoietic cell signaling pathways.